Expression of plasminogen activator inhibitor-1 and tissue plasminogen activator in the kidney of KKAy mice with type 2 diabetes.
- Author:
Li-meng CHEN
1
;
Xue-wang LI
;
Li-wei HUANG
;
Yan LI
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Diabetes Mellitus, Experimental; metabolism; Diabetes Mellitus, Type 2; metabolism; Extracellular Matrix; metabolism; Kidney; metabolism; Male; Mice; Mice, Inbred C57BL; Plasminogen Activator Inhibitor 1; biosynthesis; genetics; RNA, Messenger; biosynthesis; genetics; Tissue Plasminogen Activator; biosynthesis; genetics
- From: Acta Academiae Medicinae Sinicae 2005;27(3):344-348
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the role of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) in the accumulation of extracellular matrix (ECM) in the kidney of KKAy mice with type 2 diabetes.
METHODSKKAy mice, a type 2 diabetic animal model, and C57BL-J mice were sacrificed at 16, 20, and 24 weeks of age, respectively. The local expression of renal laminin was analyzed with immunohistochemistry. Chromogenic substance was used to show the activity of PAI-1. The mRNA expression of tPA was determined by RT-PCR. The mRNA expression of PAI-1 was measured by reverse transcription-polymerase chain reaction (RT-PCR).
RESULTSLaminnin expression was significantly increased in all age groups of KKAy mice. The tPA mRNA was significantly lower than that in C57BL mice, especially at the age of 16w (only 47%). Otherwise the PAI-1 mRNA expression was remarkably up-regulated than that in C57BL mice.
CONCLUSIONIn type 2 diabetes KKAy mice, the accumulation of ECM may be associated with the abnormal expression of PAI-1/tPA mRNA.
